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A series of 39 boron-dipyrrolylmethenes (BODIPYs) have been synthesized and characterized. Their
spectroscopic properties, degree of lipophilicity, chemical stability under irradiation, and singlet-oxygen
generation rate have also been studied. These compounds differ in the presence of ethyl groups (group
A), hydrogens (group B) or iodines (group C) on the 2,6 positions; these appendices confer particular
characteristics to each group. The presence of an aromatic substituent or hydrogen on the indacene 8
position produces 13 different molecules of each group. Besides the effects exerted by the group or atom
on the 2,6 positions, the substituent on the 8 position exerts a further effect on the physico-chemical
parameters, thus the desired properties of BODIPYs, concerning ﬂuorescence, lipophilicity, and singlet
oxygen production can be modulated accordingly.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
After their introduction in 1968,1 the 4,4-diﬂuoro-4-bora-3a,4a-
diaza-s-indacene chromophores (Fig. 1), also known as boron dipyr-
rolylmethenes but commonlynamedwith the acronymBODIPY, have
shown phenomenal growth in their applications and synthetic vari-
ants since the early nineties.2 Currently, BODIPY derivatives are
employed in awide range of applications, e.g., as tunable laser dyes,3
chemosensors,4 ﬂuorescent switches,5 and biological labels.6 BODIPY
dyes possess many distinctive and biologically favorable properties,
such as highmolar absorption coefﬁcients, highﬂuorescent quantum
yields, and longwavelengths of emission.7 Moreover, photochemical
properties and chemical stabilities of the boron dipyrrolylmethene
chromophore are higher than those of other dyes.dacene
ositions
ion
4-bora-3a,4a-diaza-s-indacene
x: þ39 0332 421554; e-mail
All rights reserved.The absorption and emission characteristics of BODIPYs can be
tuned by introducing appropriate substituents onto the BODIPY
framework. The effect is particularly evident when the substituent
is linked to a carbon atom of a pyrrole ring.8 On the contrary, the
presence of an aromatic chemical group tethered on position 8
(meso) exerts a very weak effect, however it has been reported that
the presence of a strong electron-withdrawing group, such as CF3,
causes a deep bathochromic shift as compared to congeners with
an aryl substituent on the same position.9
The weak effect of the aromatic ring is explained by the feeble
electronic interaction between the aromatic ring and the BODIPY
framework. In fact the two moieties are almost orthogonal to each
other.10 Therefore, any structural difference on themeso-aryl group
does not noticeably inﬂuence the intensity and wavelength of the
absorption and ﬂuorescence bands, however the degree of polarity
of this moiety could modulate the lipophilic/hydrophilic balance of
the molecule.
The presence of substituents on the 2,6 positions of the pyrrole
units (both are b-pyrrole positions) exerts some evident effects; for
instance the presence of alkyl groups or heavy atoms has a direct
inﬂuence on the energy of the HOMOeLUMO orbitals, and on the
population of the triplet state thus inﬂuencing the phenomena of
absorption and emission of UVevis radiation.11
Beside the well known ﬂuorescence property that makes these
molecules very useful as biomarkers, an important new ﬁeld of
application of BODIPYs concerns photodynamic therapy (PDT) as
they can be used as photosensitizers once opportunely modiﬁed.12
PDT is an emerging modality for the eradication of some kind of
S. Banﬁ et al. / Tetrahedron 69 (2013) 4845e48564846small solid cancers.13 It is based on the intravenous or topical ad-
ministration of a drug (a photosensitizer, PS) followed by irradia-
tion, after a predetermined incubation period, with a visible light of
an appropriatewavelength, which leads the formation of a PS in the
excited state. The absorbed energy is then transferred to the
neighboring molecules, especially to intracellular molecular oxy-
gen, thus producing toxic oxygen radical species able to induce cell
death. The basic factor inﬂuencing PDT outcome is the capability of
the photosensitizer to produce singlet oxygen, the main cytotoxic
agent involved in the killing of tumor cells in the PDT therapeutic
process.14 The rate of singlet oxygen production of a PS is regulated
by the efﬁciency of a spin-forbidden electronic transition, indicated
as intersystem crossing (ISC), in which the electrons switch from
the singlet to the triplet excited state. The introduction on the
BODIPY frame of bulky and electron rich atoms, such as the large
halogens Br and I, is known to have an inﬂuence over the rates of
ISC; this is named the heavy-atom effect.15 In fact, two different
type of heavy-atom effect are recognized: the internal heavy-atom
effect, inwhich heavy atoms are directly attached to themolecule,16
and the external heavy-atom effect, in which the photosensitizer is
positioned in a heavy atom-containing environment, the ﬁrst being
much more effective than the second one.17
In this manuscript we report the synthesis of a wide series of
BODIPY derivatives featuring alkyl, hydrogen or iodine substituents
on the 2,6-pyrrolylmethene positions, thus forming three different
groups of molecules. Thirty-six of these compounds bear an aro-
matic ring with variable structural characteristics on the meso po-
sition, whereas three compounds have an unsubstituted meso
position featuring only a hydrogen atom. All of thesemolecules haveNH
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Scheme 1. Synthesis, structures, and acronyms of the BODIPY dyes (* forbeen characterized and studied for their different physico-chemical
properties, such as lipophilicity, absorption, and emission spec-
troscopies, chemical stability and, ﬁnally, the relative rate of singlet
oxygen (1O2) generation. In particular the ﬂuorescence quantum
yields are measured in three solvents of different polarity, and the
results discussed on the basis of the level of the HOMO energy of the
aromatic moiety present on the 8 position of the BODIPY skeleton.
Preliminary in vitro photodynamic studies, concerning the mole-
cules characterized by the presence of iodine atoms on the dipyr-
rolylmethene frame, are also discussed in our text.
2. Results and discussion
2.1. Synthesis
The BODIPY derivatives were synthesized via acid catalyzed
condensation of aromatic aldehydes and pyrroles following the
general methods described by Akkaya and Liu.18 Two differently
substituted pyrroles, the 2,4-dimethylpyrrole and the 3-ethyl-2,4-
dimethylpyrrole, were used in the condensation reactions with
aromatic aldehydes, carried out in dichloromethane (DCM) or tet-
rahydrofuran (THF) in the presence of triﬂuoroacetic acid (TFA). The
obtained dipyrrolylmethane intermediate was subsequently oxi-
dized with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) and
then treated with BF3$Et2O in the presence of Et3N, in the same
reaction ﬂask, yielding the desired pure BODIPY in fairly good
yields after a single chromatographic separation.
Following this synthetic pathway (Scheme 1), we obtained
BODIPYs characterized by the presence of ethyl appendices on theOH
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the structure of the per-iodinated compounds 4c and 5c see Fig. 3).
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hydrogen atoms on the same positions (group B).
In this synthetic procedure, it is worth noticing that, in almost
every acid catalyzed condensation between pyrrole and aromatic
aldehyde, a low percentage (3e7%) of the unsubstituted BODIPYs
13a,b may be isolated as a byproduct (Fig. 2). It seems that no
correlation can be found between the nature of the aromatic
moiety and the isolated yield of compounds 13a,b.B
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Fig. 2. Chemical structure of the byproducts 13a and 13b.The BODIPYs characterized by hydrogen-bearing 2,6-positions
(R1¼H, Group B) are modiﬁed by the insertion of two iodine
atoms (Scheme 1) leading to the compounds of Group C. In the
iodination process, we found that the conditions reported in the
literature (I2, HIO3, 60 C, 20 min)19 cause partial degradation of the
boronedipyrrolylmethenes skeleton, leading to extremely low
yields of the desired compound. Lowering the temperature to
20e25 C and increasing the reaction time to 15e18 h allows the
recovery of the iodinated derivatives in fairly good yields (>80%).
It must be considered that, in the presence of a phenolic group
on the meso position of the BODIPY skeleton, iodination also oc-
curs on the aromatic ring. This undesired reaction cannot be avoid
as the hydroxyl substituent promotes electrophilic aromatic sub-
stitution, which occurs on the phenyl contemporaneously with the
iodination of the 2,6 free positions. More speciﬁcally, two iodine
atoms have been introduced on the 30,50 positions, when the ar-
omatic ring was characterized by the presence of the hydroxyl
group at the 40 position (compound 4c), whilst in the case of
a phenyl bearing the hydroxyl on position 30 the introduction of
only one iodine atom at the 40 position has been observed (com-
pound 5c) (Fig. 3).OH
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Fig. 3. Chemical structure of the two per-iodinated meso phenyl BODIPYs 4c and 5c.Compounds 10aec were synthesized from the corresponding
compounds 9aec via nucleophilic aromatic substitution of the
ﬂuorine in position 40 of the pentaﬂuorophenyl group with 4-
methoxybenzylmercaptan. The reaction was carried out in THF, at
reﬂux for 30 min, in the presence of K2CO3 as base (Scheme 2).
In Tables 1e3 are reported the physico-chemical properties of
the synthesized BODIPYs.2.2. Analytical data
2.2.1. HPLC retention time. The lipophilicity of organic compounds
is commonly evaluated measuring the molecule partition co-
efﬁcient (P) between 1-octanol and water. The values obtained
following UVevis analysis of both the organic and the aqueous
phase are generally expressed as Log P; in this case values >3 in-
dicate highly lipophilic molecules. This method cannot be applied
when highly lipophilic (or, vice versa, hydrophilic) compounds are
considered, as the absorbance of one or the other phase is too low
to be spectrophotometrically detected. When spectroscopic
methods cannot be applied, a relative scale of the lipophilicity of
chemical compounds belonging to a homogeneous series can be
determinedmeasuring the HPLC retention time (tR). Performing the
analyses on a reversed phase column (C18 is the most commonly
used), under standardized conditions (eluant and ﬂux), the most
lipophilic compound will show the highest tR. The average value of
the tR ðMtR Þ of each BODIPY group clearly indicates that the bulky
and low polarity iodine atoms confer high lipophilicity to all the
BODIPYs of the group C ðMtR Þ ¼ 1305400; the group A molecules,
featuring the ethyl, show a ðMtR Þ ¼ 901000 while the H substituted
BODIPYs (group B) are characterized by the shortest retention time
with a ðMtR Þ ¼ 700800: These data indicate the possibility to modify
the degree of lipophilicity of this class of molecules according to the
nature of the group or atom placed on the 2,6 positions; as we will
see later on (paragraph 2.2.4), the effect of having aromatic group in
the meso position can further partially modify the hydrophilic/li-
pophilic nature of BODIPYs.
2.2.2. Absorption and ﬂuorescence spectroscopy. Both the max-
imumeminimum values range and the average values of the ex-
tinction coefﬁcients at lmaximum indicate the highest absorbance
of the hydrogen substituted compounds (group B) with a mean
value of 84,300, followed by those featuring the ethyl groups
(group A, mean 76,300), while the presence of the iodine atoms
further decreases the mean value of absorbance (group C, mean
73,000) although to a low extent. In every group, the absorbances in
water (W) are lower than those registered in DCM, with the ratios
AbsW/AbsDCM ranging from 0.50 to 0.80 for most of the molecules.
This occurrence is easily ascribable to the formation of aggregates
of the lipophilic compounds in the aqueous medium. Indeed the
largest decrease of absorbance is always associated with a broad-
ening of the peak, as evidenced by the two or three times greater
values of the full width at half maximum (FWHM) in water with
respect to those in DCM. In particular, the BODIPYs of group B show
the highest variability in the aqueous phase, indeed the highest
value of FWHM is observed for the compound bearing a highly li-
pophilic naphthyl group (7b, FWHM¼80) and the lowest for the
more polar, hydroxy substituted, compounds 4b and 5b
(FWHM¼27 and 28, respectively).
As far as groups A and C are concerned the presence of the non-
polar and larger substituents on the 2,6 positions makes these
compounds generally more lipophilic with respect to those of
group B. It is conceivable that the meso-aryl group exerts a lower
effect on the absorption band broadening in the water phase.
The l max values are instead well correlated to the presence of
the particular substituents on the 2,6 positions of the dipyrro-
lylmethene skeleton, as the presence of ethyl groups causes
a bathochromic shift of about 20 nm, and the iodines produce
a 30 nm shift with respect to the values recorded for the hydrogen
bearing BODIPYs (group B). This latter shows lmax range between
500 and 518 nm, whereas the lmax of compounds listed in groups
A and C can be found in the range 524e536 nm and 532e548 nm,
respectively. The low difference about the observed position of the
l max between the compound bearing two ethyls and those bear-
ing two iodines (about 10 nm of difference) does not account for the
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Scheme 2. Nucleophilic aromatic substitution on pentaﬂuorophenyl substituted BODIPYs 9aec with 4-methoxybenzylmercaptan, affording compounds 10aec.
Table 1
Physico-chemical properties of the compounds of group A (2,6-ethyl substituted BODIPYs)
‘meso’ substituent 3(DCM) 524<l<536 FWHM
(DCM)
3(W) 520<l<532
( 3Ratio W/DCM)
FWHM (W)
(Ratio W/DCM)
HPLC tRe(RP C18)
(min)
1O2a
1a [4,5-(MeO)2,3-I]ePh 92,600 27 75,100 (0.81) 57 (2.1) 1002700 4.92102
2a 4-MeOePh 66,200 27 55,400 (0.83) 62 (2.3) 905700 5.75102
3a 3-MeOePh 84,300 27 60,100 (0.73) 62 (2.3) 905000 6.81102
4a 4-OHePh 63,400 27 48,700 (0.77) 61 (2.3) 704400 5.83102
5a 3-OHePh 72,000 27 58,900 (0.82) 62 (2.3) 800000 6.81102
6a 4-MeOeNaphth 80,500 23 61,500 (0.76) 62 (2.7) 1201200 6.69102
7a 4,7-(MeO)2eNaphth 83,100 23 64,300 (0.77) 57 (2.5) 1102400 5.18102
8a 2,6-Cl2ePh 72,100 28 41,000 (0.57) 65 (2.3) 401700 1.17101
9a F5ePh 56,800 28 44,100 (0.77) 65 (2.3) 804100 5.98102
10a (4-BzS)eF4ePh 60,200 29 42,400 (0.70) 60 (2.0) 1001400 1.80101
11a 4-Py 71,400 27 57,400 (0.80) 62 (2.3) 805200 9.17102
12a 3-Py 57,000 29 53,800 (0.94) 65 (2.2) 802700 1.06101
13a H 133,000 23 57,600 (0.44) 75 (2.2) 801900 5.50102
Range 56.8O133103 41O75103 401700O1201200 4.92O18102
Mean 76,300 55,400 901000 7.92102
a 1O2 Comparative singlet-oxygen generation relative to Rose Bengal.
Table 2
Physico-chemical properties of the compounds of group B (2,6-hydrogen substituted BODIPYs)
‘meso’ substituent 3(DCM) 500<l<518 FWHM
(DCM)
3(W) 496<l<510
(ratio W/DCM)
FWHM (W)
(Ratio W/DCM)
HPLC tRe(RP C18)
(min)
1O2a
1b [4,5-(MeO)2,3-I]ePh 109,800 19 74,900 (0.68) 52 (2.7) 704800 1.17102
2b 4-MeOePh 72,900 21 68,000 (0.93) 63 (3.0) 703100 8.89103
3b 3-MeOePh 62,200 20 48,600 (0.79) 57 (2.8) 702800 8.91103
4b 4-OHePh 65,200 21 63,400 (0.96) 28 (1.3) 602200 8.13103
5b 3-OHePh 79,800 21 79,000 (0.99) 27 (1.3) 602900 1.90102
6b 4-MeOeNaphth 103,300 20 76,800 (0.74) 58 (2.9) 805900 2.25102
7b 4,7-(MeO)2eNaphth 94,300 19 61,000 (0.64) 80 (4.2) 801600 4.95102
8b 2,6-Cl2ePh 91,100 22 43,000 (0.47) 67 (3.0) 400800 1.86102
9b F5ePh 61,500 22 49,700 (0.81) 66 (3.0) 604800 4.28102
10b (4-BzS)eF4ePh 85,700 34 54,600 (0.63) 60 (1.8) 705000 3.98102
11b 4-Py 85,700 28 60,100 (0.69) 71 (2.5) 605300 9.96102
12b 3-Py 69,800 29 46,800 (0.67) 61 (2.1) 604000 1.68102
13b H 115,000 17 71,100 (0.62) 68 (4.0) 603100 1.64102
Range 61.5O115103 43O79103 400800O805900 0.81O9.96102
Mean 84,300 61,300 700800 2.79102
a 1O2 Comparative singlet-oxygen generation relative to Rose Bengal.
S. Banﬁ et al. / Tetrahedron 69 (2013) 4845e48564848different electronic effect of the two moieties, as the former exert
only a weak positive inductive (þI) effect while the latter has
a weak electron-withdrawing effect (I) and a positive mesomeric
(þM) effect due to the electron pairs present on the iodine atoms,thus it seems that the bulkiness of the substituent is the main pa-
rameter affecting the l max.
The ﬂuorescence data, reported in Table 3 for the 2,6-iodine
substituted BODIPYs and in Table 4 for the other BODIPYs, have
Table 4
HOMO energy levels and quantum yield of ﬂuorescence in various solvents of the 2,6-ethyl substituted BODIPYs (part A) and of the 2,6-hydrogen substituted BODIPYs (part B)
HOMO energy (eV) Solvent lem (nm) Fﬂuo HOMO energy (eV) Solvent lem (nm) Fﬂuo
1 8.8353 a Hexane 542 0.38 8 9.4204 a Hexane 551 0.52
DCM 544 0.45 DCM 548 0.65
MeCN 542 0.27 MeCN 548 0.49
b Hexane 519 0.37 b Hexane 527 0.79
DCM 518 0.50 DCM 526 0.88
MeCN 517 0.41 MeCN 523 0.62
2 9.1150 a Hexane 541 0.40 9 10.5472 a Hexane 559 0.29
DCM 539 0.50 DCM 561 0.34
MeCN 538 0.43 MeCN 558 0.20
b Hexane 513 0.59 b Hexane 528 0.68
DCM 513 0.74 DCM 531 0.74
MeCN 511 0.31 MeCN 530 0.60
3 9.1150 a Hexane 540 0.37 10 9.2170 a Hexane 558 0.42
DCM 541 0.48 DCM 557 0.56
MeCN 538 0.34 MeCN 557 0.38
b Hexane 512 0.51 b Hexane 527 0.71
DCM 513 0.67 DCM 533 0.81
MeCN 512 0.30 MeCN 525 0.59
4 9.1745 a Hexane 537 0.41 11 10.1047 a Hexane 546 0.35
DCM 539 0.58 DCM 541 0.50
MeCN 539 0.39 MeCN 545 0.33
b Hexane 517 0.65 b Hexane 520 0.66
DCM 513 0.70 DCM 516 0.83
MeCN 513 0.57 MeCN 518 0.53
5 9.1745 a Hexane 540 0.47 12 10.1047 a Hexane 542 0.40
DCM 540 0.50 DCM 541 0.50
MeCN 538 0.32 MeCN 542 0.42
b Hexane 515 0.49 b Hexane 521 0.61
DCM 514 0.62 DCM 514 0.62
MeCN 512 0.59 MeCN 510 0.56
6 8.5161 a Hexane 543 0.54 13 a Hexane 543 0.24
DCM 542 0.53 DCM 544 0.34
MeCN 541 0.33 MeCN 540 0.43
b Hexane 517 0.67 b Hexane 514 0.87
DCM 517 0.70 DCM 514 0.88
MeCN 515 0.12 MeCN 510 0.76
7 8.4026 a Hexane 542 0.39
DCM 543 0.44
MeCN 541 0.32
b Hexane 518 0.45
DCM 518 0.51
MeCN 517 0.009
All dataweremeasured in the presence of up 1% acetone as a cosolvent. The quantum yield of ﬂuorescence (Fﬂuo) was determined using ﬂuorescein as a standard (0.85 in 0.1M
NaOH). HOMO energy levels of the corresponding benzene moieties were calculated with HYPERCHEM software after minimization to their lowest energy conformation using
the semi-empirical PM3 method in HYPERCHEM software too.
Table 3
Physico-chemical properties of the compounds of group C (2,6-iodine substituted BODIPYs)
‘meso’ substituent 3(DCM) 532<l<548 FWHM
(DCM)
3(W) 526<l<540
( 3ratio W/DCM)
FWHM (W)
(Ratio W/DCM)
HPLC tRe(RP C18)
(min)
Fﬂuo
a (l, nm)
(DCM)
1O2b
1c [4,5-(MeO)2,3-I]ePh 89,300 29 68,200 (0.76) 56 (1.9) 1500400 0.01 (556) 1.27
2c 4-MeOePh 61,500 30 35,000 (0.57) 77 (2.6) 1404200 0.02 (551) 1.04
3c 3-MeOePh 69,900 23 49,800 (0.71) 61 (2.6) 1402700 0.02 (552) 1.27
4c 4-OHePh 73,700 25 38,600 (0.50) 70 (2.8) 1305000 0.04 (555) 1.45
5c 3-OHePh 67,700 22 53,000 (0.77) 77 (3.5) 1202100 0.05 (551) 1.48
6c 4-MeOeNaphth 72,000 28 51,000 (0.70) 58 (2.1) 2004400 0.02 (555) 1.27
7c 4,7-(MeO)2eNaphth 97,800 28 73,200 (0.74) 58 (2.1) 1703200 0.01 (556) 1.33
8c 2,6-Cl2ePh 76,400 29 54,300 (0.71) 77 (2.6) 503300 0.02 (555) 1.53
9c F5ePh 50,500 43 38,600 (0.78) 90 (2.1) 120080 0.01 (578) 1.20
10c (4-BzS)eF4ePh 48,300 32 33,400 (0.68) 70 (2.2) 1502700 0.04 (566) 1.17
11c 4-Py 78,800 35 49,500 (0.62) 75 (2.1) 1200600 0.02 (562) 1.99
12c 3-Py 67,100 36 30,400 (0.44) 87 (2.4) 1100700 0.03 (560) 1.81
13c H 96,500 37 60,300 (0.62) 71 (1.9) 1100500 0.02 (555) 1.53
Range 97.8O48.3103 30.4O73.2103 503300O2004000 0.01O0.05 1.04O1.99
Mean 73,000 48,900 1305400 2.38102
a F represents quantum efﬁciency of ﬂuorescence with ﬂuorescein (0.1 M NaOH, 0.85) as reference.
b 1O2 Comparative singlet-oxygen generation relative to Rose Bengal.
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S. Banﬁ et al. / Tetrahedron 69 (2013) 4845e48564850been normalized with respect to the value obtained using ﬂuo-
rescein as standard.20 It is known that the ﬂuorescent properties of
such dyes are controlled by electron transfer from the donormoiety
(the aryl substituent in the meso position in our case) to the ac-
ceptor ﬂuorophore (BODIPY core), therefore a peculiar dependence
on solvent polarity could be observed.4a,21 Consequently we have
measured the quantum yield of ﬂuorescence of groups A and B in
three different solvents, hexane, dichloromethane (DCM), and
acetonitrile (MeCN), characterized by particularly different di-
electric constants, 1.89, 9.14, and 37.5, respectively. The BODIPYs
included in group C were not considered in this study, as the iodine
atoms exert a well known ISC effect, thus shifting the singlet ex-
cited state into the lower energetic triplet state causing a nearly
complete inhibition of ﬂuorescence to the advantage of a very high
rate of singlet-oxygen generation.
The comparison of Fﬂuo obtained in the three solvents indicates
that all compounds belonging to group B show a Fﬂuo> than those
of group A and that in the whole set of compounds DCM allows
a Fﬂuo higher than hexane and MeCN. Among these last two sol-
vents the more polar acetonitrile inhibits the ﬂuorescence to
a greater extent with respect to hexane, however only when the
aryl meso substituent had a higher HOMO energy level was an
important inhibiting effect on ﬂuorescence observed, as evidenced
by the values obtained for compound 7b and, partially, for 6b.
The inhibiting effect of polar solvents is absent in BODIPYs
characterized by the presence of an aromatic ring in the meso po-
sition when its HOMO energy is very low, i.e., when electron-
withdrawing groups are present on the aryl.
Compounds 8a and 8b show the highest Fﬂuo values in groups A
and B, respectively. This can be explained by considering the
presence of two chlorine atoms, bulky groups, on the ortho and
ortho0 positions of the 8-aryl substituted BODIPYs. In fact, it has
been reported that the molecular rigidity arising from the in-
troduction of bulky groups at the ortho positions minimizes the
decrease in ﬂuorescence intensity due to a nonradiative pathway.22
A particular case concerns compound 13b that shows the same
high Fﬂuo value of 8b, although it features the greatest number of
hydrogen atoms in the indacene structure (positions 2, 6, and 8).
2.2.3. Singlet oxygen (1O2) production rate. For BODIPYs to be used
as biological markers,6 their ﬂuorescence should be at the possible
utmost or, alternatively, if they have to act as photosensitizers then
a high singlet oxygen production is required. Both processes take
place after light absorption, and the structural differences in the
BODIPY skeleton allow the different outcome of the energy loss
from the excited state. In the ﬁrst case the energy loss occurs from
the singlet excited state through a strong light emission, possibly in
the red visible region of light. On the contrary, when a massive
production of singlet oxygen is required to impair the close bi-
ological structures, the triplet excited state must be involved from
which the energy loss via light emission becomes a forbidden
process; as a consequence this excited state can be lost with dif-
ferent pathways dissipating the energy to neighboring molecules.
Among them, molecular oxygen is one of the favored targets, thus
producing 1O2, a short living but highly toxic compound when
generated inside cells. The relative rates of singlet oxygen pro-
duction are generally measured by comparing the results with
a referencemolecule; in this work Rose Bengal, a widely recognized
singlet oxygen producer, was used as standard.23 The amount of 1O2
produced by each photosensitizer was indirectly determined
measuring the disappearance of the absorption band, at 410 nm, of
the 1,3-diphenylisobenzofuran (DPBF), a well known 1O2 scaven-
ger.24 The experiments were carried out following a literature
method, using isopropanol as solvent with a 50 mM initial con-
centration of DPBF and in the presence of 2.5 mM of BODIPY. Irra-
diation was obtained with a green LED device. The green light waschosen to ensure a good overlap between the lmax of absorbance of
these BODIPYs and the emission wavelength of the light, thus
obtaining a maximum excitation power.
The values reported in Tables 1e3 show the great difference
between the iodinated BODIPYof group C and the other two groups.
All the BODIPYs of group C are largely more efﬁcient than those
belonging to groups A and B that indeed show a very poor 1O2
outcome. It must be pointed out that the rate of singlet oxygen
production, higher than the value obtained with Rose Bengal,
measured for the BODIPYs belonging to the group C, make these
molecules particularly interesting for their application in photo-
dynamic therapy. In particular an impressive rate of 1O2 production
is observed for the pyridyl bearing compounds 11c and 12c that
show a 2-fold increased rate with respect to Rose Bengal.
The last comment concerns the inﬂuence of external iodine
atoms on the efﬁcacy of 1O2 production rate; among the reported
BODIPYs four of them feature one extra iodine atom on the meso
phenyl (1aec, 5c) and one molecule bears two iodine atoms (4c). In
principle, an increased 1O2 production rate might be expected, due
to an external heavy-atom effect, however the values calculated for
these compounds are slightly higher than the mean value of the
corresponding group, thus indicating the absence of an external
heavy-atom effect.
2.2.4. Effect of the substituent on position 8 (meso position) on the
lipophilic/hydrophilic balance. The ﬁrst observation is the compa-
rable effect exerted by the meso substituent in each group, irre-
spective of the different substituent present in the 2,6 BODIPY
positions. Besides the effect on absorbance, the aromatic group
partially modiﬁes the hydrophilicity of these molecules. Concern-
ing the HPLC retention times, the aromatic moieties confer a higher
lipophilicity to the BODIPYs as compared with the meso H
substituted compounds. More precisely themolecules featuring the
lipophilic naphthyl groups (6aec, 7aec) show a greater afﬁnity for
the reversed phase HPLC column (C18), as witnessed by the highest
tR in each group. A similar effect was also found for compounds
10aec, all characterized by the presence of a large and non-polar
aromatic appendix. In the iodinated compounds of group C, the
presence of one or two more iodine atoms on the meso phenyl ring
(compounds 4c and 5c) does not seem to increase the lipophilicity,
probably because the iodine in the 2,6 positions already confers
a high hydrophobic character to these molecules. The presence of
electron-withdrawing atoms or the presence of a hydroxyl group
on the meso aromatic rings makes the BODIPY more polar, as
shorter tR were observed (compounds 4, 5, 9, 11, and 12 in every
group). Particularly striking is the effect of the two chlorine atoms
present in compounds 8aec, conferring the highest hydrophilicity
to these molecules, as witnessed by the low afﬁnity for the sta-
tionary phase used. The tR of compounds 8aec are by far the
shortest in each group and do not differ greatly with the nature of
the group present on the 2,6 pyrrole positions.
The last aspect to be considered is the 1O2 production that is
remarkable for the BODIPYs of group C only. In this group, the
ﬂuorescence is inhibited and the formation of the triplet excited
state is favored by the presence of the iodine atoms on the 2,6 po-
sitions. An impressive rate of 1O2 is observed for the pyridyl bearing
compounds 11c and 12c, which show a 2-fold increased rate with
respect to Rose Bengal, the reference compound known for its efﬁ-
cacy in singlet oxygen production. These last molecules should be
considered in the application of BODIPYs in the ﬁeld of PDT.
2.3. Photodegradation of BODIPY dyes
In in vivo PDT applications, the photodegradation of the pho-
tosensitizer plays an important role. Indeed, any PS with a high
stability can turn out to be highly phototoxic for a prolonged time
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where sunlight can produce serious damage. On the other hand,
a PS quickly decomposed by light can hardly be applied in therapy,
as its efﬁcacy could end before complete treatment of the diseased
tissue. For this reason we have evaluated the stability of group C
BODIPYs, those producing a good amount of 1O2, and, for the sake of
comparison, some analogues of the two other groups. Thus the
stability of the series of compounds 5aec, 7aec, and 11aec were
studied irradiating an aqueous 10 mM solution of each BODIPY with
the green LED and recording the absorbance every 15 min. The
results were plotted (Abs vs time) and the values of half-
degradation time evaluated with an exponential equation. As re-
ported in Fig. 4 for a selected example with BODIPYs 7aec, it is
evident that the degradation process rapidly occurs at high con-
centrations, whereas it slows down when the majority of the PS is
already decomposed, thus indicating that a bimolecular process
occurs under irradiation. It must be considered that the PS con-
centrations used in these analyses are much higher than those used
in in vitro PDT experiments because of the necessity to start with
the absorbance values at about 0.5e0.6 for each compound. The
average half-degradation time is 30 min for group A BODIPYs, and
50e60 min for the compounds of both group B and C, thus we
decide to lengthen the time of irradiation to 120 min, as the cell
killing experiments rely on the presence, although it could be in
low percentage, of intact PS up to the end of the irradiation period.0
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Fig. 4. Plot of photodegradation rate of the 7aec BODIPYs.2.4. In vitro preliminary evaluation of the photodynamic
activity
The BODIPYs of group C were tested to study their phototoxic
activity against ovarian carcinoma SKOV3 cells. For this purpose, cell
cultureswere treatedwith increasing concentrationsof theBODIPYs.
After 24 h of dark incubation, they were irradiated with a green LED
device for 2h (ﬂuence33 J/cm2) and theefﬁcacyof the treatmentwas
determined with theMTT assay. The intrinsic effects of the PSs were
assessed by omitting the irradiation step from the treatment pro-
tocol; it was found negligible in all cases up to 5 mM, thus indicating
photoactivation to be an absolute requirement for the activity of
these molecules. The 13 compounds of group C were found to be
particularly active (IC50 values in the nM range), however the one
featuring the hydrogen on the meso position was less active (13c,
IC50¼28.75 nM) with respect to the meso-aryl derivatives
(0.65<IC50<8.03 nM). From these results it is understood that the
aromatic ring positioned in the 8 position of the dipyrrolylmethene
skeleton exerts an important effect on the BODIPYs activity. In par-
ticular, compounds 8c and 2c showed interestingly high photody-
namic efﬁciencies as the IC50 valueswere found 0.772 and 0.650 nM,
respectively. To emphasize this, we are currently evaluating the re-
lationship between chemical structure andphotodynamic activity of
these molecules with QSAR studies in order to plan the synthesis of
new structure with, possibly, higher PDT efﬁcacy.3. Conclusion
The data presented in this work allows us to choose the reagents
to synthesize BODIPYs suitable either for diagnostic purposes or for
photodynamic therapy in which the fundamental features are de-
termined by the presence of peculiar groups or atoms on the 2,6
positions. These characteristics can be further ﬁnely tuned by in-
troducing aromatic rings with electron-withdrawing or electron-
donating effects. In particular, the polarity of the BODIPY frame
can be increased or diminished according to the groups hanging
from themeso-aryl substituent, thus making these molecules more
or less prone to cell penetration and, possibly, also with a particular
internal distribution in the various cell organelles.We have recently
demonstrated that a few of the molecules here reported have
shown interesting photosensitizing capabilities against human
colorectal carcinoma (HCT116) cells in in vitro assays.12 Further-
more compound 11c can be alkylated on the pyridyl nitrogen thus
affording cationic BODIPYs, which have been found to be suitable
for a photo induced killing effect against bacteria.25 The systematic
study of these kind of molecules can bring further insight to the
development of new photosensitizers suitable for both cancer cell
killing or the eradication of localized infections.4. Experimental section
4.1. General
IR spectra weremeasured on a Nicolet Avatar 360 FT-IR. 1H NMR
and 13C NMR spectra were recorded on a Bruker 400 MHz spec-
trometer in CDCl3 or DMSO-d6; chemical shifts are expressed in
parts per million relative to chloroform (7.28) and are reported as s
(singlet), d (doublet), t (triplet), m (multiplet), br s (broad singlet).
Mass spectrometric measurements were performed on a Bruker
Esquire 3000 Plus. Elemental analyses were performed on a Ther-
moQuest NA 2100, C, H, N analyzer, equipped with an electronic
mass ﬂow control and thermal conductivity detector. Merck 60 F254
silica gel precoated sheets (0.2 mm thick) were used for analytical
thin-layer chromatography (TLC). Silica gel 60 (70e230 mesh,
Merck) was used for column chromatography. Aromatic aldehydes,
2,4-dimethyl-3-ethylpyrrole, and 2,4-dimethylpyrrole were com-
mercial products (SigmaeAldrich) and used as received. Dichloro-
methane used for BODIPY synthesis was distilled from CaCl2
directly into the reaction ﬂask. HPLC analyses were conducted with
an Agilent 1100 Series instrument coupled with a diode array de-
tector. The instrument was ﬁtted with a 2504.6 mm column
(Supelco, Ascentis) packed with C-18 reversed-phase particles
(5 mm) and operated with an isocratic elutionwith MeCN at 0.5 mL/
min. The green LED array is composed of 123 W diodes (lmax of
emission at 525 nm, width at half maximum of 70 nm), placed on
an 11 cm diameter disk, and equipped with a heatsinker. The
electric supply was ensured by a 50 W current transformer. This
array was placed above the plate at such a distance as to produce
a homogeneous irradiated area with a ﬂuence rate (irradiance) of
1.31104 W/cm2 at 525 nm (l of maximum emission), as de-
termined with an LI-COR 1800 spectroradiometer.4.2. Synthesis
General comment on BODIPY synthesis. The acid catalyzed
condensation step between pyrroles and aromatic aldehydes al-
ways produces the compound lacking the aromatic ring in variable
yields ranging from 3 to 7%. This arises from the loss of the aromatic
moiety from the aldehyde carbon instead of the hydrogen in the
oxidation process from dipyrrolylmethane to the corresponding
methene.
S. Banﬁ et al. / Tetrahedron 69 (2013) 4845e48564852As an example, the reaction of 3-ethyl-2,4-dimethylpyrrole with
3-iodo-4,5-dimethoxybenzaldehyde gives 2,6-diethyl-1,3,5,7-
tetramethyl-8-H-4,40-diﬂuoroboradiazaindacene (compound 13a)
as byproduct of 1a.
2,6-Diiodo-1,3,5,7-tetramethyl-8-H-4,40-diﬂuoroboradiazainda-
cene (13c),12a 2,6-diethyl-1,3,5,7-tetramethyl-8-(4-methoxyphe-
nyl)-4,40-diﬂuoroboradiazaindacene (2a),12b 1,3,5,7-tetramethyl-8-
(4-methoxyphenyl)-4,40-diﬂuoroboradiazaindacene (2b),12b 2,6-
diiodo-1,3,5,7-tetramethyl-8-(4-methoxyphenyl)-4,40-diﬂuorobor-
adiazaindacene (2c),12b 2,6-diethyl-1,3,5,7-tetramethyl-8-(4-hyd-
roxyphenyl)-4,40-diﬂuoroboradiazaindacene (4a),12b 1,3,5,7-tetra-
methyl-8-(4-hydroxyphenyl)-4,40-diﬂuoroboradiazaindacene (4b),12b
2,6-diethyl-1,3,5,7-tetramethyl-8-(3-hydroxyphenyl)-4,40-diﬂuorob-
oradiazaindacene (5a),12b 1,3,5,7-tetramethyl-8-(3-hydroxyphenyl)-
4,40-diﬂuoroboradiazaindacene (5b),12b 1,3,5,7-tetramethyl-8-(4-pyr-
idyl)-4,40-diﬂuoroboradiazaindacene (11b),25 2,6-diiodo-1,3,5,7-
tetramethyl-8-(4-pyridyl)-4,40-diﬂuoroboradiazaindacene (11c),25
were synthesized as previously described.
4.2.1. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(3-iodo-4,5-dimethoxyphe-
nyl)-4,40-diﬂuoroboradiaza indacene (1a). 3-Iodo-4,5-dimethoxy-
benzaldehyde (1.5 mmol) and 2,4-dimethyl-3-ethylpyrrole
(3.3 mmol) were dissolved in absolute CH2Cl2 (30 mL) under N2
atmosphere, 10 drops of TFA were added and the solution was
stirred at rt overnight or until TLC analysis showed complete con-
sumption of the aldehyde. At this time of DDQ (2.5 mmol) were
added and stirring continued for 20 min. Then, Et3N (4 mL) and
BF3$OEt2 (4 mL) were added. The mixture was stirred for 12 h then
the organic layer containing the crude product was subsequently
washed three times with water; the organic solution was dried
over Na2SO4, and evaporated to dryness. The raw material was
chromatographed (SiO2, petroleum ether/CH2Cl2, 6:4) affording
280 mg (yield: 33%) of 1a in the form of orange needles, mp
220 C. EA: calcd for C25H30BF2IN2O2: C, 53.03; H, 5.34; N, 4.95;
found: C, 53.47; H, 5.38; N, 4.92; UV visðCH2Cl2Þ: 528 nm
( 3¼92,600); IR (KBr, cm1) 2934 (CH), 2862 (CH), 1526, 1172, 988,
524 (CI); 1H NMR (CDCl3) d 1.00 (t, 6H, J¼8 Hz, 2 CH3), 1.35 (s, 6H,
2 CH3), 2.32 (q, 4H, J¼8 Hz, 2 CH2), 2.55 (s, 6H, 2 CH3), 3.76 (s,
3H, OCH3), 3.84 (s, 3H, OCH3), 6.75 (br s, 1H), 7.25 (br s, 1H); 13C
NMR (CDCl3) d 12.12, 12.50, 15.23, 17.39, 56.03, 55.21, 86.10, 117.22,
128.53, 133.88, 138.00, 139.21, 153.76, 154.35, 155.72; MS (ESI):
MNaþ, found: 588.98 calcd for C25H30BF2IN2O2 566.23; HPLC: re-
tention time¼1002700 (98.8%).
Compound 13a, mp 204 C; EA: calcd for C17H23BF2N2: C, 67.12;
H, 7.62; N, 9.21; found: C, 67.54; H, 7.65; N, 9.30; UV visðCH2Cl2Þ:
526 nm ( 3¼133,000); IR (KBr, cm1) 2956 (CH), 2924 (CH), 2839
(CH),1526,1172, 988; 1H NMR (CDCl3) d 1.00 (t, 6H, J¼8 Hz, 2 CH3),
2.18 (s, 6H, 2 CH3), 2.39 (q, 4H, J¼8 Hz, 2 CH2), 2.54 (s, 6H, 2
CH3), 6.96 (s, 1H); 13C NMR (CDCl3) d 12.02, 12.61, 14.88, 16.99,
131.29, 134.00, 137.13, 139.52, 153.21; MS (ESI): MNaþ, found:
327.00 calcd for C17H23BF2N2 304.19; HPLC: retention time¼801900
(99.58%).
4.2.2. 1,3,5,7-Tetramethyl-8-(3-iodo-4,5-dimethoxyphenyl)-4,40-di-
ﬂuoroboradiazaindacene (1b). 3-Iodo-4,5-dimethoxybenzaldehyde
(1.5 mmol) and 2,4-dimethylpyrrole (3.3 mmol) were reacted as
described for compound 1a. The raw material was chromato-
graphed (SiO2, petroleum ether/CH2Cl2, 1:1) affording 140 mg
(yield: 18%) of 1b as orange needles, mp 218 C; EA: calcd for
C21H22BF2IN2O2 C, 49.44; H, 4.35; N, 5.49; found: C, 49.08; H, 4.36;
N, 5.53; UV visðCH2Cl2Þ: 504 nm ( 3¼109,800); IR (KBr, cm1) 2946
(CH), 2854 (CH), 1534, 1184, 990, 524 (CI); 1H NMR (CDCl3) d 1.43 (s,
6H, 2 CH3), 2.48 (s, 6H, 2 CH3), 3.76 (s, 3H, OCH3), 3.83 (s, 3H,
OCH3), 5.92 (s, 2H), 6.75 (d, J¼3 Hz, 1H), 7.23 (d, J¼3 Hz, 1H); 13C
NMR (CDCl3) d 14.78, 56.03, 55.38, 87.29, 116.32, 130.22, 135.22,
138.10, 138.98, 153.26, 154.61, 155.29; MS (ESI): MNaþ, found:533.01 calcd for C21H22BF2IN2O2 510.12; HPLC: retention time-
¼704800 (99.8%).
Compound 13b, mp 214 C; EA: calcd for C13H15BF2N2: C, 62.94;
H, 6.09; N, 11.29; found: C, 63.02; H, 6.10; N, 11.33; UV visðCH2Cl2Þ:
506 nm ( 3¼115,000); IR (KBr, cm1) 2968 (CH), 2920 (CH), 2865
(CH), 1529, 1184, 974; 1H NMR (CDCl3) d 2.17 (s, 6H, 2 CH3), 2.47 (s,
6H, 2 CH3), 5.96 (s, 1H), 6.95 (s, 2H); 13C NMR (CDCl3) d 14.65,
127.29,134.01,137.63,139.78,154.01; MS (ESI): MNaþ found: 270.96
calcd for C13H15BF2N2 248.08; HPLC: retention time¼603100 (100%).
4.2.3. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(3-iodo-4,5-dimethoxyphe-
nyl)-4,40-diﬂuoroboradiaza indacene (1c). Compound 1b
(0.069 mmol), I2 (0.138 mmol), and HIO3 (0.138 mmol) were dis-
solved in EtOH (5 mL). This mixture was stirred for 15e18 h at rt.
The solution was then washed with water and extracted three
times with CH2Cl2, the organic phase was dried over Na2SO4, and
evaporated to dryness. The crude product was puriﬁed by column
chromatography (SiO2, petroleum ether/CH2Cl2, 1:1) affording
28 mg (yield: 53%) of 1c as red needles, mp>300 C; EA: calcd for
C21H20BF2I3N2O2 C, 33.10; H, 2.65; N, 3.68; found: C, 33.21; H, 2.67;
N, 3.66; UV visðCH2Cl2Þ: 538 nm ( 3¼89,300); IR (KBr, cm1) 2922
(CH), 2851 (CH), 1530, 1174, 994, 524 (CI); 1H NMR (CDCl3) d 1.48 (s,
6H, 2 CH3), 2.58 (s, 6H, 2 CH3), 3.76 (s, 3H, OCH3), 3.84 (s, 3H,
OCH3), 6.70 (d, J¼2 Hz, 1H), 7.21 (d, J¼2 Hz, 1H); 13C NMR (CDCl3)
d 15.09, 56.09, 55.42, 87.69, 88.14, 115.97, 135.38, 138.10, 138.68,
153.15, 154.48, 155.66; MS (ESI): M1þ found: 760.74 calcd for
C21H20BF2I3N2O2 761.92; HPLC: retention time¼1500400 (99.6%).
4.2.4. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(3-methoxyphenyl)-4,40-di-
ﬂuoroboradiazaindacene (3a). 2,4-Dimethyl-3-ethylpyrrole (3.3
mmol) and 3-methoxybenzaldehyde (1.5 mmol) were made to react
as described for compound 1a. The raw material was puriﬁed by
column chromatography (SiO2, petroleum ether/CH2Cl2, 6:4)
affording 236 mg (yield: 38%) of 3a as orange needles, mp 184 C;
EA: calcd for C24H29BF2N2O C, 70.25; H, 7.12; N, 6.83; found: C, 70.48;
H, 7.13; N, 6.81; UV visðCH2Cl2Þ: 524 nm ( 3¼84,300); IR (KBr, cm1)
2976 (CH), 2922 (CH), 2854 (CH), 1528, 1179, 992, 754; 1H NMR
(CDCl3) d 1.01 (t, 6H, J¼7.5 Hz, 2 CH3), 1.37 (s, 6H, 2 CH3), 2.33 (q,
4H, J¼7.5 Hz, 2 CH2), 2.55 (s, 6H, 2 CH3), 3.84 (s, 3H, OCH3), 6.85
(m, 1H), 6.89 (d, J¼8 Hz, 1H), 7.02 (dd, J¼8, 3 Hz, 1H), 7.41 (t, J¼8 Hz,
1H); 13C NMR (CDCl3) d 12.13,12.74,15.18,17.25, 56.04,116.19,128.01,
128.59,131.43,133.02,138.59,139.69,152.99,155.15;MS (ESI): M1þ
found: 409.11 calcd for C24H29BF2N2O 410.31; HPLC: retention
time¼905000 (98.4%).
4.2.5. 1,3,5,7-Tetramethyl-8-(3-methoxyphenyl)-4,40-diﬂuoroboradi-
azaindacene (3b). 3-Methoxybenzaldehyde (1.5 mmol) and 2,4-
dimethylpyrrole (3.3 mmol) were made to react as described for
compound 1a. The raw material was puriﬁed by column chroma-
tography (SiO2, petroleum ethereCH2Cl2, 1:1) affording 131 mg
(yield: 25%) of 3b as orange needles, mp 180 C; EA: calcd for
C20H21BF2N2O C, 67.82; H, 5.98; N, 7.91; found: C, 67.99; H, 6.00; N,
7.91; UV visðCH2Cl2Þ: 500 nm ( 3¼62,200); IR (KBr, cm1) 2928
(CH), 2841 (CH), 1526, 1183, 998, 752; 1H NMR (CDCl3) d 1.47 (s, 6H,
2 CH3), 2.57 (s, 6H, 2 CH3), 3.84 (s, 3H, OCH3), 6.00 (s, 2H), 6.85
(br s, 1H), 6.89 (d, J¼8 Hz, 1H), 7.02 (dd, J¼8, 2 Hz, 1H), 7.41 (t,
J¼8 Hz, 1H); 13C NMR (CDCl3) d 14.79, 55.55, 114.75, 121.08, 121.36,
127.85, 129.48, 141.81, 143.39, 155.66, 158.64; MS (ESI): M1þ
found: 353.28 calcd for C20H21BF2N2O 354.20; HPLC: retention
time¼702800 (97.2%).
4.2.6. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(3-methoxyphenyl)-4,40-di-
ﬂuoroboradiazaindacene (3c). Compound 3b (0.127 mmol), I2
(0.254 mmol), and HIO3 (0.254 mmol) were made to react as de-
scribed for compound 1c. The crude product was puriﬁed by col-
umn chromatography (SiO2, petroleum ethereCH2Cl2, 1:1)
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calcd for C20H19BF2I2N2O C, 39.64; H, 3.16; N, 4.62; found: C, 40.01;
H, 3.18; N, 4.65; UV visðCH2Cl2Þ: 534 nm ( 3¼61,500); IR (KBr, cm1)
2922 (CH), 2850 (CH), 1533, 1177, 991, 753; 524 (CI); 1H NMR
(CDCl3) d 1.38 (s, 6H, 2 CH3), 2.57 (s, 6H, 2 CH3), 3.74 (s, 3H,
OCH3), 6.71 (m, 1H), 6.76 (d, J¼4 Hz, 1H), 6.97 (dd, J¼8, 2 Hz, 1H),
7.35 (t, J¼8 Hz, 1H); 13C NMR (CDCl3) d 15.23, 55.67, 86.35, 115.01,
122.12, 122.39, 127.36, 141.02, 143.25, 155.99, 158.72; MS (ESI):
M1 found: 604.86 calcd for C20H19BF2I2N2O 605.99; HPLC: re-
tention time¼1402700 (99.1%).
4.2.7. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(4-hydroxy-3,5-diiodophenyl)-
4,40-diﬂuoroboradiaza indacene (4c). Compound 4b (0.088 mmol), I2
(0.166 mmol), and HIO3 (0.166 mmol) were made to react as de-
scribed for compound 1c. The crude product was puriﬁed by column
chromatography (SiO2, petroleum ethereCH2Cl2, 4:6) affording
45 mg (yield: 61%) of 4c as red needles, mp>300 C; EA: calcd for
C19H15BF2I4N2O C, 27.05; H,1.79; N, 3.32; found: C, 26.93; H,1.78%; N,
3.30; UV visðCH2Cl2Þ: 532 nm ( 3¼73,700); IR (KBr, cm1) 3450 (OH),
2922 (CH), 1535, 1305, 1172, 993, 524 (CI); 1H NMR (CDCl3) d 1.54 (s,
6H, 2 CH3), 2.63 (s, 6H, 2 CH3), 7.61 (s, 2H); 13C NMR (CDCl3)
d 15.02, 81.66, 85.02, 121.33, 127.31, 129.66, 141.99, 142.88, 155.71,
156.32; MS (ESI): M1 found: 842.52 calcd for C19H15BF2I4N2O
843.76; HPLC: retention time¼1305000 (100.0%).
4.2.8. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(3-hydroxy-4-iodophenyl)-
4,40-diﬂuoroboradiaza indacene (5c). Compound 5b (0.088 mmol),
I2 (0.166 mmol), and HIO3 (0.166 mmol) were made to react as
described for compound 1c. The crude product was puriﬁed by
column chromatography (SiO2, petroleum ethereCH2Cl2, 6:4)
affording 40 mg (yield: 63%) of 5c as red needles, mp>300 C; EA:
calcd for C19H16BF2I3N2O C, 31.79; H, 2.25; N, 3.90; found: C, 32.00;
H, 2.27; N, 3.92; UV visðCH2Cl2Þ: 536 nm ( 3¼67,700); IR (KBr,
cm1) 3481 (OH), 2961 (CH), 2927 (CH), 2869 (CH),1538,1474,1190,
977, 526 (CI); 1H NMR (CDCl3) d 1.42 (s, 6H, 2 CH3), 2.56 (s, 6H, 2
CH3), 5.54 (s, 1H, OH), 6.52 (dd, J¼8, 2 Hz, 1H), 6.82 (d, J¼2 Hz, 1H);
7.74 (d, J¼8 Hz, 1H); 13C NMR (CDCl3) d 14.78, 81.98, 85.74, 115.33,
124.78, 130.96, 136.35, 139.77, 143.09, 153.71, 156.32; MS (ESI):
M1 found: 716.67 calcd for C19H16BF2I3N2O 717.86; HPLC: re-
tention time¼1202100 (97.2%).
4.2.9. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(4-methoxynaphthalene)-
4,40-diﬂuoroboradiaza indacene (6a). 4-Methoxy-1-naphthal-
dehyde (1.5 mmol) and 2,4-dimethyl-3-ethylpyrrole (3.3 mmol)
were made to react as described for compound 1a. After stirring for
12 h, the organic layer containing the crude product was washed
with a solution of HCl (10%), two times with water and one time
with NaCl saturated solution (Brine); the organic solutionwas dried
over Na2SO4 and evaporated to dryness. The raw material was
chromatographed on silica gel (petroleum ethereCH2Cl2, 6:4)
affording 280 mg (yield: 41%) of 6a as orange needles, mp 241 C;
EA: calcd for C28H31BF2N2O C, 73.05; H, 6.79; N, 6.09; found: C,
72.88; H, 6.80; N, 6.10; UV visðCH2Cl2Þ: 528 nm ( 3¼80,500); IR
(KBr, cm1) 2964 (CH), 2854 (CH), 1538, 1502, 1189, 977; 1H NMR
(CDCl3) d 0.87 (t, 6H, J¼8 Hz, 2 CH3), 0.93 (s, 6H, 2 CH3), 2.18 (q,
4H, J¼8 Hz, 2 CH2), 2.48 (s, 6H, 2 CH3), 4.01 (s, 3H, OCH3), 6.82 (d,
J¼9 Hz, 1H), 7.19 (t, J¼9 Hz, 1H), 7.35 (t, J¼9, 2 Hz, 1H), 7.41 (t, J¼9,
2 Hz,1H), 7.62 (d, J¼9 Hz, 1H), 8.23 (d, J¼9 Hz,1H); 13C NMR (CDCl3)
d 11.56, 13.01, 14.96, 16.85, 55.70, 101.93, 103.76, 116.21, 117.88,
120.52, 124.29, 124.02, 127.66, 131.32, 132.47, 134.45, 138.79, 139.22,
153.63, 156.09; MS (ESI): M1 found: 459.20 calcd for
C28H31BF2N2O 460.37; HPLC: retention time¼1201200 (93.5%).
4.2.10. 1,3,5,7-Tetramethyl-8-(4-methoxynaphthalene)-4,40-diﬂuoro-
boradiazaindacene (6b). 4-Methoxy-1-naphthaldehyde (1.5 mmol)
and 2,4-dimethylpyrrole (3.3 mmol) were made to react asdescribed for compound 1a. At the end of the reaction the organic
layer was treated as above. The rawmaterial was chromatographed
on silica gel (petroleum ethereCH2Cl2, 1:1) affording 270mg (yield:
41%) of 6b as orange needles, mp 252 C; EA: calcd for
C24H23BF2N2O C, 71.30; H, 5.73; N, 6.93; found: C, 70.97; H, 5.68; N,
6.89; UV visðCH2Cl2Þ: 504 nm ( 3¼103,300); IR (KBr, cm1) 2956
(CH), 2852 (CH), 1537, 1506, 1187, 1153, 977; 1H NMR (CDCl3) d 1.11
(s, 6H, 2 CH3), 2.59 (s, 6H, 2 CH3), 4.07 (s, 3H, OCH3), 5.91 (s, 2H),
6.90 (d, J¼9 Hz,1H), 7.25 (d, J¼9 Hz,1H), 7.42 (td, J¼9, 2 Hz,1H), 7.49
(td, J¼9, 2 Hz,1H), 7.70 (d, J¼9 Hz,1H), 8.31 (d, J¼9 Hz,1H); 13C NMR
(CDCl3) d 11.61, 13.11, 55.82, 102.32, 103.57, 116.39, 117.91, 120.36,
124.41, 124.27, 127.61, 128.32, 132.56, 134.51, 138.66, 138.94, 153.68,
155.98; MS (ESI): M1þ found: 403.17 calcd for C24H23BF2N2O
404.26; HPLC: retention time¼805900 (94.0%).
4.2.11. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(4-methoxynaphthalene)-
4,40-diﬂuoroboradiaza indacene (6c). Compound 6b (0.074 mmol),
I2 (0.148 mmol), and HIO3 (0.148 mmol) were made to react as
described for compound 1c. The crude product was recovered by
ﬁltration then crystallized out of MeOH affording 30 mg (yield:
62%) of 6c as red needles, mp>300 C; EA: C, 43.94; H, 3.23; N, 4.27;
found: C, 43.90; H, 3.22; N, 4.28; UV visðCH2Cl2Þ: 538 nm
( 3¼72,000); IR (KBr, cm1) 2956 (CH), 2852 (CH), 1529, 1305, 1172,
994; 769, 524 (CI); 1H NMR (CDCl3) d 1.07 (s, 6H, 2 CH3), 2.60 (s,
6H, 2 CH3), 4.01 (s, 3H, OCH3), 6.83 (d, J¼8 Hz, 1H), 7.17 (d, J¼8 Hz,
1H), 7.38 (td, J¼8, 1 Hz, 1H), 7.42 (td, J¼8, 1 Hz, 1H), 7.55 (d, J¼8 Hz,
1H), 8.27 (d, J¼8 Hz, 1H); 13C NMR (CDCl3) d 11.79, 14.16, 55.61,
84.98, 103.14, 104.01, 116.32, 117.80, 121.21, 124.56, 124.95, 127.32,
132.11, 134.63, 138.79, 138.38, 153.57, 155.26; MS (ESI): M1þ
found: 654.93 calcd for C24H21BF2I2N2O 656.05; HPLC: retention
time¼2004400 (99.7%).
4.2.12. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(4,7-dimethoxynaphthale-
ne)-4,40-diﬂuoroboradiaza indacene (7a). 4,7-Dimethoxy-1-
naphthaldehyde (1.5 mmol) and 2,4-dimethyl-3-ethylpyrrole
(3.3 mmol) were made to react as described for compound 1a. At
the end of the reaction the organic layer was treated as above. The
raw material was chromatographed (SiO2, petroleum
ethereCH2Cl2, 7:3) affording 124 mg (yield: 17%) of 7a as orange
needles, mp 280 C; EA: calcd for C29H33BF2N2O2 C, 71.03; H, 6.78;
N, 5.71; found: C 71.37; H, 6.83, N, 5.73; UV visðCH2Cl2Þ: 528 nm
( 3¼83,100); IR (KBr, cm1) 2962 (CH), 2926 (CH), 2869 (CH), 1536,
1316, 1187, 976; 1H NMR (CDCl3) d 0.87 (t, 6H, J¼8 Hz, 2 CH3), 1.02
(s, 6H, 2 CH3), 2.19 (q, 4H, J¼8 Hz, 2 CH2), 2.50 (s, 6H, 2 CH3),
3.66 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 6.70 (d, J¼8 Hz, 1H), 6.91 (d,
J¼3 Hz, 1H), 7.06 (dd, J¼9, 3 Hz, 1H), 7.13 (d, J¼8 Hz, 1H), 8.15 (d,
J¼9 Hz, 1H); 13C NMR (CDCl3) d 11.41, 12.70, 14.79, 17.18, 55.68,
55.71, 102.21, 103.88, 117.71, 120.88, 124.08, 124.40, 127.35, 131.85,
132.62, 134.54, 138.46, 139.17, 153.64, 156.41, 159.16; MS (ESI):
MNaþ found: 513.12 calcd for C29H33BF2N2O2 490.39; HPLC: re-
tention time¼1102400 (98.6%).
4.2.13. 1,3,5,7-Tetramethyl-8-(4,7-dimethoxynaphthalene)-4,40-di-
ﬂuoroboradiazaindacene (7b). 4,7-Dimethoxy-1-naphthaldehyde
(1.5 mmol) and 2,4-dimethyl-3-ethylpyrrole (3.3 mmol) were
made to react as described for compound 1a. At the end of the
reaction the organic layer was treated as above. The raw material
was puriﬁed by column chromatography (SiO2, petroleum ether/
CH2Cl2, 4:6) affording 124 mg (yield: 19%) of 7b as orange needles,
mp 234 C; EA: calcd for C25H25BF2N2O2 C, 69.14; H, 5.80; N, 6.45;
found: C 68.99; H, 5.79; N, 6.48; UV visðCH2Cl2Þ: 504 nm
( 3¼94,300); IR (KBr, cm1) 2921 (CH), 2851 (CH), 1548, 1199, 1078,
976, 838; 1H NMR (CDCl3) d 1.11 (s, 6H, 2 CH3), 2.52 (s, 6H, 2
CH3), 3.66 (s, 3H, OCH3), 3.98 (s, 3H, OCH3), 5.85 (s, 2H), 6.70 (d,
J¼8 Hz, 1H), 6.89 (d, J¼3 Hz, 1H), 7.07 (dd, J¼9, 3 Hz, 1H), 7.12 (d,
J¼8 Hz, 1H), 8.16 (d, J¼9 Hz, 1H); 13C NMR (CDCl3) d 11.39, 12.76,
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128.85, 129.61, 134.39, 138.51, 139.46, 153.92, 156.16, 158.62; MS
(ESI): M1þ found: 433.19 calcd for C25H25BF2N2O2 434.29; HPLC:
retention time¼801600 (99.4%).4.2.14. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(4,7-dimethoxynaphtha-
lene)-4,40-diﬂuoroboradiaza indacene (7c). Compound 7b
(0.069 mmol), I2 (0.138 mmol), and HIO3 (0.138 mmol) were made
to react as described for compound 1c. The crude product was re-
covered by ﬁltration then crystallized out of MeOH affording 30 mg
(yield: 63%) of 7c as red needles, mp>300 C; EA: calcd for
C25H23BF2I2N2O2 C, 43.77; H, 3.38; N, 4.08; found: C, 43.98; H, 3.41;
N, 4.12; UV visðCH2Cl2Þ: 538 nm ( 3¼97,800); IR (KBr, cm1) 2965
(CH), 2840 (CH), 1532, 1189, 984, 836, 524 (CI); 1H NMR (CDCl3)
d 1.11 (s, 6H, 2 CH3), 2.59 (s, 6H, 2 CH3), 3.64 (s, 3H, OCH3), 3.99
(s, 3H, OCH3), 6.71 (d, J¼8 Hz, 1H), 6.80 (d, J¼3 Hz, 1H), 7.09 (d,
J¼3 Hz, 1H), 7.11 (d, J¼3 Hz, 1H), 8.18 (d, J¼8 Hz, 1H); 13C NMR
(CDCl3) d 11.93, 12.62, 55.68, 55.75, 86.11, 102.60, 103.09, 117.42,
120.57, 124.11, 124.62, 127.31, 129.19, 134.62, 138.38, 139.45, 154.31,
155.81, 158.20; MS (ESI): M1þ found: 684.95 calcd for
C25H23BF2I2N2O2 686.08; HPLC: retention time¼1703200 (99.4%).4.2.15. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(2,6-dichlorophenyl)-4,40-
diﬂuoroboradiazaindacene (8a). 2,4-Dimethyl-3-ethylpyrrole (3.3
mmol) and 2,6-dichlorobenzaldehyde (1.5 mmol) were made to
react as described for compound 1a. The raw material was chro-
matographed (SiO2, petroleum ether/CH2Cl2, 1:1) affording 230 mg
(yield: 34%) of 8a as brown needles, mp 255 C; EA: calcd for
C23H25BCl2F2N2 C, 61.50; H, 5.61; N, 6.24; found: C 61.79; H, 5.64; N,
6.18; UV visðCH2Cl2Þ: 536 nm ( 3¼72,100); IR (KBr, cm1) 2960
(CH), 2924 (CH), 1545, 1186, 973, 788; 1H NMR (CDCl3) d 0.93 (t, 6H,
J¼8 Hz, 2 CH3), 1.31 (s, 6H, 2 CH3), 2.25 (q, 4H, J¼8 Hz, 2 CH2),
2.47 (s, 6H, 2 CH3), 7.29 (dd, J¼9, 7 Hz, 1H), 7.32-7.42 (m, 2H); 13C
NMR (CDCl3) d 14.95, 15.58, 16.35, 17.42, 128.41, 129.98, 130.12,
131.64, 132.21,134.42,144.26,157.18; MS (ESI): M1þ found: 447.09
calcd for C23H25BCl2F2N2 449.17; HPLC: retention time¼401700
(96.3%).
4.2.16. 1,3,5,7-Tetramethyl-8-(2,6-dichlorophenyl)-4,40-diﬂuorobora-
diazaindacene (8b). 2,4-Dimethylpyrrole (3.3 mmol) and 2,6-
dichlorobenzaldehyde (1.5 mmol) were made to react as de-
scribed for compound 1a. The raw material was chromatographed
(SiO2, petroleum ethereCH2Cl2, 1:1) affording 257 mg (yield: 44%)
of 8b as brown needles, mp 255 C; EA: calcd for C19H17BCl2F2N2 C,
58.06; H, 4.36; N, 7.13; found: C 57.89; H, 4.38; N, 7.08;
UV visðCH2Cl2Þ: 512 nm ( 3¼91,100); IR (KBr, cm1) 2956 (CH), 2924
(CH), 2854 (CH), 1551, 1465, 1192, 976; 1H NMR (CDCl3) d 1.41 (s, 6H,
2 CH3), 2.50 (s, 6H, 2 CH3), 5.93 (s, 2H), 7.28 (d, J¼9, 7 Hz, 1H),
7.35e7.41 (m, 2H); 13C NMR (CDCl3) d 15.69, 16.73, 127.32, 129.09,
130.58, 131.60, 132.72, 134.48, 144.36, 156.95; MS (ESI): M1þ
found: 391.08 calcd for C19H17BCl2F2N2 393.07; HPLC: retention
time¼400800 (99.6%).
4.2.17. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(2,6-dichlorophenyl)-4,40-
diﬂuoroboradiazaindacene (8c). Compound 8b (0.237 mmol), I2
(0.474 mmol), and HIO3 (0.474 mmol) were made to react as de-
scribed for compound 1c. The crude product was puriﬁed by col-
umn chromatography (SiO2, petroleum ether/CH2Cl2, 1:1) affording
101 mg (yield: 66%) of 8c as red needles mp 210 C; EA: calcd for
C19H15BCl2F2I2N2 C, 35.39; H, 2.34; N, 4.34; found: C, 35.40; H, 2.34;
N, 4.31; UV visðCH2Cl2Þ: 548 nm ( 3¼76,400); IR (KBr, cm1) 2965
(CH), 2942 (CH), 2848 (CH), 1548, 1462, 1188, 970, 528 (CI); 1H NMR
(CDCl3) d 1.42 (s, 6H, 2 CH3), 2.58 (s, 6H, 2 CH3), 7.34 (d, J¼9, 7 Hz,
1H), 7.37e7.45 (m, 2H); 13C NMR (CDCl3) d 15.84, 16.37, 86.06,
128.98, 130.40, 131.68, 132.95, 134.79, 144.15, 157.94; MS (ESI):M1þ found: 642.79 calcd for C19H15BCl2F2I2N2 644.86; HPLC: re-
tention time¼503300 (92.5%).
4.2.18. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(2,3,4,5,6-pentaﬂuorophe-
nyl)-4,40-diﬂuoroboradiaza indacene (9a). 2,4-Dimethyl-3-ethyl-
pyrrole (3.3 mmol) and 2,3,4,5,6-pentaﬂuorobenzaldehyde
(1.5 mmol) were made to react as described for compound 1a. The
raw material was chromatographed (SiO2, petroleum ethereCH2Cl2,
1:1), the fractions were collected to dryness and the product was
treated with cold methanol affording 112 mg (yield: 16%) of 9a as
orange needles, mp 206 C; EA: calcd for C23H22BF7N2 C, 58.75; H,
4.72; N, 5.96; found: C, 59.03; H, 4.76; N, 6.00. UV visðCH2Cl2Þ:
534 nm ( 3¼56,800); IR (KBr, cm1) 2956 (CH), 2932 (CH), 2850 (CH),
1548, 1468, 1180, 970; 1H NMR (CDCl3) d 1.02 (t, 6H, J¼8 Hz, 2 CH3),
1.51 (s, 6H, 2 CH3), 2.33 (q, 4H, J¼8Hz, 2 CH2), 2.54 (s, 6H, 2 CH3);
13C NMR (CDCl3) d 14.78, 15.32, 16.59, 17.21, 131.25, 132.36, 134.54,
140.26, 142.16 (dd, J¼248.9, 13.9 Hz), 143.39 (dd, J¼249.9, 15.1 Hz),
147.52 (dd, J¼241.3, 14.9 Hz), 155.11; MS (ESI): M1þ found: 469.17
calcd for C23H22BF7N2 470.23; HPLC: retention time¼804100 (96.0%).
4.2.19. 1,3,5,7-Tetramethyl-8-(2,3,4,5,6-pentaﬂuorophenyl)-4,40-di-
ﬂuoroboradiazaindacene (9b). 2,3,4,5,6-Pentaﬂuorobenzaldehyde
(1.5 mmol) and 2,4-dimethylpyrrole (3.3 mmol) were made to re-
act as described for compound 1a. The rawmaterial was puriﬁed by
column chromatography (SiO2, petroleum ether/CH2Cl2, 7:3), the
fractions were collected to dryness and the product precipitated
from methanol affording 92 mg (yield: 15%) of 9b as green needles,
mp 220 C; EA: calcd for C19H14BF7N2 C, 55.10; H, 3.41; N, 6.76;
found: C, 54.87; H, 3.43; N, 6.70; UV visðCH2Cl2Þ: 518 nm
( 3¼61,500); IR (KBr, cm1) 2948 (CH), 2836 (CH), 1549, 1478, 1184,
961; 1H NMR (CDCl3) d 1.53 (s, 6H, 2 CH3), 2.49 (s, 6H, 2 CH3),
5.98 (s, 2H); 13C NMR (CDCl3) d 14.45, 16.67, 129.13, 132.22, 135.63,
139.13, 141.13 (dd, J¼249.6, 12.8 Hz), 144.13 (dd, J¼250.0, 15.2 Hz),
147.63 (dd, J¼243.4, 11.9 Hz), 155.02; MS (ESI): M1þ found: 413.02
calcd for C19H14BF7N2 414.13; HPLC: retention time¼604800 (99.5%).
4.2.20. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(2,3,4,5,6-pentaﬂuorophe-
nyl)-4,40-diﬂuoroboradiaza indacene (9c). Iodine (0.170 mmol),
iodic acid (0.170 mmol), and compound 9b (0.085 mmol) were
made to react as reported for compound 1c. The crude product was
puriﬁed by column chromatography (SiO2, petroleum
ethereCH2Cl2, 1:1) affording 54 mg (yield: 96%) of 9c as red nee-
dles, mp 250 C; EA: calcd for C19H12BF7I2N2 C, 34.27; H, 1.82; N,
4.21; found: C, 34.08; H, 1.81; N, 4.18; UV visðCH2Cl2Þ: 548 nm
( 3¼50,500); IR (KBr, cm1) 2948 (CH), 2836 (CH), 1549, 1478, 1184,
961. 1H NMR (CDCl3) d 1.56 (s, 6H, 2 CH3), 2.59 (s, 6H, 2 CH3); 13C
NMR (CDCl3) d 15.53, 16.12, 85.01, 131.62, 135.21, 138.11, 140.29 (dd,
J¼241.2, 11.2 Hz), 143.26 (dd, J¼251.2, 13.9 Hz), 146.32 (dd, J¼243.2,
12.8 Hz), 154.66; MS (ESI): M1 found: 664.7 calcd for
C19H12BF7I2N2 665.92; HPLC: retention time¼1200800 (94.9%).
4.2.21. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(2,3,5,6-tetraﬂuoro-3-[(4-
methoxybenzyl)sulfanyl]phenyl)-4,40-diﬂuoroboradiazaindacene
(10a). Compound 9a (0.128mmol) was dissolved in anhydrous THF
(8 mL), and the solution was stirred under N2 for 5 min. After this
period K2CO3 (354 mg, 2.56 mmol) was added and the mixture was
brought to reﬂux. A solution of 4-methoxy-a-toluenethiol (1 mL,
2.56 mmol), dissolved in anhydrous THF (9 mL), was then added
dropwise over 15 min and the reaction was kept under reﬂux for
30 min. After cooling, the mixture was evaporated under vacuum.
The crude product was puriﬁed by column chromatography (SiO2,
petroleum ether/CH2Cl2, 1:1), precipitated frommethanol affording
52 mg (yield 67%) of 10a as red-purple needles, mp 170 C; EA:
calcd for C31H31BF6N2OS C, 61.60; H, 5.17; N, 4.63; found: C, 62.11;
H, 5.21; N, 4.66; UV visðCH2Cl2Þ: 532 nm ( 3¼60,200); IR (KBr,
cm1) 2957 (CH), 2924 (CH), 2852 (CH), 1549, 1471, 1186, 969, 829;
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2.24 (q, 4H, J¼8 Hz, 2 CH2), 2.45 (s, 6H, 2 CH3), 3.70 (s, 3H, OCH3),
4.10 (s, 2H, SCH2), 6.98 (d, J¼9 Hz, 2H), 7.11 (d, J¼9 Hz, 2H); 13C NMR
(CDCl3) d 13.95, 14.72, 15.63, 16.89, 38.06, 55.45, 114.13, 116.12 (t,
J¼21.1 Hz), 124.20, 127.89, 128.35,130.68, 131.46, 140.56, 143.62 (dd,
J¼251.2, 15.9 Hz), 147.71 (dd, J¼248.0, 13.9 Hz), 157.23, 158.86; MS
(ESI): M1þ found: 603.15 calcd for C31H31BF6N2OS 604.46; HPLC:
retention time¼1001400 (99.0%).
4.2.22. 1,3,5,7-Tetramethyl-8-(2,3,5,6-tetraﬂuoro-3-[(4-methoxyben-
zyl)sulfanyl]phenyl)-4,40-diﬂuoroboradiazaindacene (10b). 4-Metho-
xy-a-toluenethiol (3 mmol) and 9b (0.15 mmol) weremade to react
as described for compound 10a. The crude product was puriﬁed by
column chromatography (SiO2, petroleum ether/CH2Cl2, 6:4),
crystallized out of methanol affording 63 mg (yield 76%) of 10b as
yellow needles, mp 188 C; EA: calcd for C27H23BF6N2OS C, 59.14; H,
4.23; N, 5.11; found: C, 59.49; H, 4.26; N, 5.12. UV visðCH2Cl2Þ:
516 nm ( 3¼92,800); IR (KBr, cm1) 2978 (CH), 2934 (CH), 2850 (CH),
1552,1465,1178, 971; 1H NMR (CDCl3) d 1.45 (s, 6H, 2 CH3), 2.56 (s,
6H, 2 CH3), 3.78 (s, 3H, OCH3), 4.18 (s, 2H, SCH2), 6.03 (s, 2H), 6.76
(d, J¼9 Hz, 2H), 7.18 (d, J¼9 Hz, 2H); 13C NMR (CDCl3) d 13.59, 14.87,
38.01, 55.44, 114.09, 115.83 (t, J¼20.4 Hz), 122.20, 124.08, 128.23,
130.08, 130.98, 141.84, 143.51 (dd, J¼250.4, 16.1 Hz), 147.63 (dd,
J¼247.9, 13.8 Hz), 157.62, 159.27; MS (ESI): M1þ found: 547.10
calcd for C27H23BF6N2OS 548.35; HPLC: retention time¼705000
(98.3%).
4.2.23. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(2,3,5,6-tetraﬂuoro-3-[(4-
methoxybenzyl)sulfanyl]phenyl)-4,40-diﬂuoroboradiazaindacene
(10c). 4-Methoxy-a-toluenethiol (0.6 mmol) and 9c (0.03 mmol)
were made to react as described for compound 10a. The crude
product was puriﬁed by column chromatography (SiO2, petroleum
ethereCH2Cl2, 1:1) affording 15 mg (yield 63%) of 6 as red needles,
mp 135 C; EA: calcd for C27H21BF6I2N2OS C, 40.53; H, 2.65; N, 3.50;
found: C, 40.59; H, 2.65; N, 3.51; UV visðCH2Cl2Þ: 546 nm
( 3¼48,300); IR (KBr, cm1) 2962 (CH), 2842 (CH), 1559, 1480, 1161,
970, 524 (CI); 1H NMR (CDCl3) d 1.48 (s, 6H, 2 CH3), 2.56 (s, 6H, 2
CH3), 3.51 (s, 2H, SCH2), 3.72 (s, 3H, OCH3), 6.77 (d, J¼9 Hz, 2H), 7.10
(d, J¼9 Hz, 2H); 13C NMR (CDCl3) d 13.69, 15.26, 38.10, 55.67, 87.11,
114.26, 115.71 (t, J¼20.1 Hz), 124.28, 128.01, 129.82, 130.53, 141.11
143.36 (dd, J¼249.3, 15.6 Hz), 147.14 (dd, J¼247.0, 12.9 Hz), 157.50,
159.15; MS (ESI): M1þ found: 799.06 calcd for C27H21BF6I2N2OS
800.14; HPLC: retention time¼1502700 (92.3%).
4.2.24. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(4-pyridyl)-4,40-diﬂuorobo-
radiazaindacene (11a). 2,4-Dimethyl-3-ethylpyrrole (620 mL,
6 mmol) and 4-pyridylcarbaldehyde (283 mL, 3 mmol) were made to
react as described for compound 1a. The raw material was puriﬁed
by column chromatography (SiO2, CH2Cl2), affording 120 mg (yield:
17%) of 11a as red needles, mp 196 C; EA: calcd for C22H26BF2N3 C,
69.30; H, 6.87; N, 11.02; found: C 69.52; H, 6.91; N, 11.11;
UV visðCH2Cl2Þ: 524 nm ( 3¼71,400); IR (KBr, cm1) 3025 (CH), 2978
(CH), 2922 (CH), 2856 (CH), 1575, 1490, 1170, 981; 1H NMR (CDCl3)
d 0.91 (t, 6H, J¼8 Hz, 2 CH3), 1.23 (s, 6H, 2 CH3), 2.22 (q, 4H,
J¼8 Hz, 2 CH2), 2.46 (s, 6H, 2 CH3), 7.23 (dd, J¼6, 1 Hz, 2H), 8.69
(dd, J¼6, 1 Hz, 2H); 13C NMR (CDCl3) d 15.21, 15.89, 16.45, 17.01,
124.13,130.39,131.52,132.12,138.42,144.26,151.12,156.81;MS (ESI):
M1þ found: 380.15 calcd for C22H26BF2N3 381.27; HPLC: retention
time¼805200 (98.5%).
4.2.25. 2,6-Diethyl-1,3,5,7-tetramethyl-8-(3-pyridyl)-4,4 0-di-
ﬂuoroboradiazaindacene (12a). 2,4-Dimethyl-3-ethylpyrrole
(620 mL, 6 mmol) and 3-pyridylcarbaldehyde (283 mL, 3 mmol)
weremade to react as described for compound 1a. The rawmaterial
was puriﬁed by column chromatography (SiO2, CH2Cl2), affording
120 mg (yield: 17%) of 12a as red needles, mp 196 C; EA: calcd forC22H26BF2N3 C, 69.30; H, 6.87; N, 11.02; found: C 69.53; H, 6.88; N,
11.05; UV visðCH2Cl2Þ: 524 nm ( 3¼57,000); IR (KBr, cm1) 3032
(CH), 2963 (CH), 2920 (CH), 2848 (CH), 1577, 1486, 1161, 972; 1H
NMR (CDCl3) d 0.91 (t, 6H, J¼8 Hz, 2 CH3),1.21 (s, 6H, 2 CH3), 2.23
(q, 4H, J¼8 Hz, 2 CH2), 2.46 (s, 6H, 2 CH3), 7.48 (dd, J¼8, 5 Hz,1H),
7.60 (dt, J¼8, 2 Hz, 1H), 8.39 (d, J¼2 Hz, 1H), 8.71 (dd, J¼5, 2 Hz, 1H);
13C NMR (CDCl3) d 14.76, 15.52, 16.01, 17.26, 123.12, 131.00, 131.65,
134.15, 138.89, 145.26, 150.96, 151.32, 156.35; MS (ESI): M1þ
found: 380.04 calcd for C22H26BF2N3 381.27; HPLC: retention
time¼802700 (98.0%).
4.2.26. 1,3,5,7-Tetramethyl-8-(3-pyridyl)-4,40-diﬂuoroboradiazainda-
cene (12b). 3-Pyridylcarbaldehyde (3 mmol) and 2,4-dimethyl-
pyrrole (6 mmol) were made to react as described for compound
1a. The raw material was puriﬁed by column chromatography
(SiO2, CH2Cl2), affording 75 mg (yield: 8%) of 11b as green needles,
mp 190 C; EA: calcd for C18H18BF2N3 C, 66.49; H, 5.58; N, 12.92;
found: C, 66.38; H, 5.54; N, 13.05; UV visðCH2Cl2Þ: 504 nm
( 3¼69,800); IR (KBr, cm1) 3028 (CH), 2969 (CH), 2840 (CH), 1571,
1488, 1167, 984; 1H NMR (CDCl3) d: 1.31 (s, 6H, 2 CH3), 2.49 (s, 6H,
2 CH3), 5.94 (s, 2H), 7.38 (dd, J¼8, 5 Hz,1H), 7.57 (dt, J¼8, 2 Hz,1H),
8.50 (d, J¼2 Hz, 1H), 8.68 (dd, J¼5, 2 Hz, 1H); 13C NMR (CDCl3)
d 14.96, 15.78, 122.85, 129.63, 131.93, 133.68, 137.32, 146.24, 150.21,
150.74, 156.21; MS (ESI): M1þ found: 324.05 calcd for
C18H18BF2N3 325.16; HPLC: retention time¼604000 (99.7%).
4.2.27. 2,6-Diiodo-1,3,5,7-tetramethyl-8-(3-pyridyl)-4,40-diﬂuoro-
boradiazaindacene (12c). Iodine (0.435 mmol), iodic acid
(0.435mmol), and compound 12b (0.217mmol) weremade to react
as reported for compound 1c. The crude product was puriﬁed by
column chromatography (SiO2, CHCl3) affording 100 mg (yield:
79%) of 12c as purple needles, mp>300 C; EA: calcd for
C18H16BF2I2N3 C, 37.47; H, 2.80; N, 7.28 found: C, 37.56; H, 2.82; N,
7.32. UV visðCH2Cl2Þ: 538 nm ( 3¼67,100); IR (KBr, cm1) 3021 (CH),
2962 (CH), 2839 (CH), 1581, 1498, 1176, 978, 528; 1H NMR (CDCl3)
d 1.56 (s, 6H, 2 CH3), 2.59 (s, 6H, 2 CH3), 7.52 (dd, J¼8, 5 Hz, 1H),
7.65 (dt, J¼8, 2 Hz, 1H), 8.58 (d, J¼2 Hz, 1H), 8.67 (dd, J¼5, 2 Hz, 1H);
13C NMR (CDCl3) d 15.63, 16.23, 87.25, 123.95, 132.24, 133.59, 139.14,
146.52, 151.58, 151.99, 155.21; MS (ESI): M1þ found: 575.21 calcd
for C18H16BF2I2N3 576.96; HPLC: retention time¼1100700 (99.1%).
4.3. Fluorescence properties and quantum yield of
ﬂuorescence
Steady-state ﬂuorescence spectroscopic studies were performed
on a Jasco FP-750 spectroﬂuorimeter. The slit width was 2.5 nm for
both excitation and emission. Values of absorbance, necessary for
the equation described below, were obtained for the same solutions
used in the ﬂuorescence measurements on a Varian Cary 50 Scan
instrument. The relative quantum efﬁciencies of ﬂuorescence of
each BODIPY derivative were obtained comparing the emission
spectra of the test sample with that of a 0.1 N NaOH solution of
ﬂuorescein excited at 490 nm, whose quantum efﬁciency literature
value is 0.85.20 The quantum efﬁciencies of ﬂuorescence (Fﬂuo) of
the BODIPYs were calculated according to the following equation
(Iﬂuo is the ﬂuorescence intensity at the speciﬁc excitation wave-
length, Abs denotes the absorbance at the excitation wavelength)
Fsamplefluo ¼ F
standard
fluo 

Isamplefluo =I
standard
fluo



Absstandard=Abssample

4.4. Comparative singlet-oxygen generation measurements
A solution of aerated isopropanol, containing 50 mM of 1,3-
diphenylisobenzofuran (DPBF) and 2.5 mM of photosensitizers
S. Banﬁ et al. / Tetrahedron 69 (2013) 4845e48564856was prepared in a glass ﬂask and kept in the dark; 2 mL of this
solution was transferred into a cuvette, placed in the UVevis in-
strument and irradiated, at rt, from the open top side with the
green LED source for the time required to observe the chemical
event (maximum 20 min). The DPBF absorbance decrease was
measured at 410 nm and at ﬁxed time intervals, as deﬁned for each
experiment. The rate of singlet oxygen production was determined
measuring the decrease in the intensity of DPBF absorbance
recorded over time. Irradiation of the DPBF-isopropanol solution in
the absence of photosensitizer (negative control) and a solution
containing 2.5 mM of Rose Bengal as a comparative control were
also carried out. The relative singlet-oxygen generation rate of each
photosensitizer was determined by using Rose Bengal as
standard.23
4.5. Photodegradation of the BODIPYs
A 10 mM Phosphate Buffer Solution (PBS) of photosensitizer was
prepared in a ﬂask. This solution was irradiated, at rt, for 2 h with
the green LED and a 1 mL sample was collected every 15 min and
analyzed with the spectrophotometer. The photodegradation rate
was determined from the plot of the decrease in the intensity of
absorbance versus time. The curves were ﬁttedwith an exponential
equation fromwhich the half-degradation time could be calculated.
4.6. Computational methods
The structures corresponding to the aromatic moieties tethered
on the BODIPY meso position were drawn and minimized to their
lowest energy conformation using a semi-empirical PM3method in
HYPERCHEM software. With the same software the HOMO energy
of the structures was calculated.
4.7. Cytotoxicity studies
Human ovarian carcinoma SKOV3 cells were obtained from the
American Type Culture Collection (Rockville, MD, USA) and main-
tained in Dulbecco’s modiﬁed Eagle medium-F12 (DMEM-F12,
Mascia-Brunelli, Milano, Italy) supplemented with 10% fetal bovine
serum, 1% glutamine, and 0.5% antibiotic mixture (penicillin,
streptomycin, and neomycin), were used for this study. The cell
lines were maintained in standard culture conditions at 37 C in
a humidiﬁed 5% CO2 atmosphere. The antiproliferative effect of the
different PS was assessed using the MTT assay.26 Brieﬂy,
5104 cells/mL were seeded onto 96-well plates and allowed to
grow for 48 h prior to treatment with different BODIPY concen-
trations. After 24 h, the BODIPY-containing medium was replaced
by PBS, and cells were irradiated under visible light for 2 h using
a green LED (ﬂuence 33 J/cm2). At the end of this time, cells were
incubated for 24 h at 37 C in drug-free medium; MTT was then
added to each well (ﬁnal concentration 0.4 mg/mL) for 3 h at 37 C
and formazan crystals formed through MTT metabolism by viable
cells were dissolved in DMSO. Optical densities were measured at
570 nm using a Universal Microplate Reader EL800 (Bio-Tek
Instruments).Possible intrinsic (i.e., non photodynamic) cytotoxic effects of
the BODIPY were assessed on control treated as described above,
with BODIPY concentrations tenfold higher than those used for PDT
experiments, omitting cell irradiation.
IC50 (i.e., the concentration affecting 50% of cells) values were
obtained by nonlinear regression analysis, using the GraphPad
PRISM 3.03 software (GraphPad Software Inc., San Diego CA).
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